These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 2959964)
41. Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin. Gelosa P; Ballerio R; Banfi C; Nobili E; Gianella A; Pignieri A; Brioschi M; Guerrini U; Castiglioni L; Blanc-Guillemaud V; Lerond L; Tremoli E; Sironi L J Pharmacol Exp Ther; 2010 Jul; 334(1):199-205. PubMed ID: 20332187 [TBL] [Abstract][Full Text] [Related]
42. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848. Arner M; Högestätt ED; Uski TK Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448 [TBL] [Abstract][Full Text] [Related]
43. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate. Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011 [TBL] [Abstract][Full Text] [Related]
44. Thromboxane does not play a significant role in acute, cold-induced vasoconstriction in Raynaud's phenomenon. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism. Gresele P; Volpato R; Migliacci R; Vezza R; Boschetti E; Nenci GG Thromb Res; 1992 May; 66(2-3):259-64. PubMed ID: 1412196 [No Abstract] [Full Text] [Related]
45. Investigations of the antiatherosclerotic effect of the thromboxane A2 receptor antagonist Daltroban. Pill J; Wolf O; Schmelz A; Stegmeier K; Metz J Z Kardiol; 1990; 79 Suppl 3():155-60. PubMed ID: 2151550 [TBL] [Abstract][Full Text] [Related]
51. Role of eicosanoids in reperfusion injury in rat liver transplantation. Post S; Palma P; Gonzalez AP; Rentsch M; Otto G; Menger MD Transplant Proc; 1993 Aug; 25(4):2547. PubMed ID: 8356663 [No Abstract] [Full Text] [Related]
53. Synergism between a phosphodiesterase inhibitor and modulators of thromboxane formation on thrombin-induced sudden death in rabbits. Smith EF; Olson RW Prog Clin Biol Res; 1987; 242():241-6. PubMed ID: 3671385 [No Abstract] [Full Text] [Related]
55. Prevention of Ca(2+)-induced or thromboxane B2-induced hepatocyte plasma membrane bleb formation by thromboxane receptor antagonists. Horton AA; Wood JM Biochim Biophys Acta; 1991 Dec; 1133(1):31-7. PubMed ID: 1836358 [TBL] [Abstract][Full Text] [Related]
56. [Aspects of new drug development]. Arai Y; Urata Y Nihon Rinsho; 1990 Jun; 48(6):1327-35. PubMed ID: 2200898 [No Abstract] [Full Text] [Related]
57. Determination of a thromboxane A2 receptor antagonist in human plasma by capillary gas chromatography with electron-capture detection. Jemal M; Ivashkiv E; Valatin P; Cohen AI J Chromatogr; 1986 Sep; 381(2):424-30. PubMed ID: 2944909 [No Abstract] [Full Text] [Related]
58. Prostanoid receptors and their biological actions. Negishi M; Sugimoto Y; Ichikawa A Prog Lipid Res; 1993; 32(4):417-34. PubMed ID: 8309950 [No Abstract] [Full Text] [Related]
59. Thromboxane A2 synthetase inhibitors. I. Syntheses and activities of various N-heteroaromatic derivatives. Kanao M; Watanabe Y; Kimura Y; Kanno H; Kubo H; Ashida S Chem Pharm Bull (Tokyo); 1988 Aug; 36(8):2968-76. PubMed ID: 3240505 [No Abstract] [Full Text] [Related]
60. Synthesis and optical resolution of an antiallergic agent KW4099 with thromboxane A2 antagonistic activity. Sugaya T; Kuge Y; Tomioka S; Tamaki K Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):238-9. PubMed ID: 1576677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]